LY4050784 clinical trials

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

This study looks at a new drug, LY4050784, for advanced or metastatic solid cancers. We want to see if it's safe and effective, on its own or with other medicines, especially for cancers with a specific gene change called SMARCA4 (BRG1).